Join Chris Toth, president, Oncology Systems Americas, for a look at Varian’s new product introductions and major initiatives highlighted at ASTRO this year:

• The 360 Oncology care management platform, the first software system designed to integrate and coordinate integrates relevant health information so cancer patients and their care teams can collaborate on the best care. 360 Oncology brings together in a single platform, radiation, medical and surgical oncology, social services, primary care physicians, as well as the patient, to facilitate true collaborative and coordinated care.
• HyperArc high definition radiotherapy, technology that unlocks the potential of using highly non-coplanar treatment strategies to usher in a new era of precision. HyperArc is designed to automate and simplify sophisticated treatments such as stereotactic radiosurgery (SRS), and make them available to more cancer patients around the world.
• Varian’s cyber-security initiative, which is transforming the company’s software platforms to help maximize the security of patient information, maintain the integrity of treatment delivery, and enhance clinical uptime by helping defend against cyber-attacks.

Accuray recently unveiled the company’s newest innovation, the Radixact Treatment Delivery System, a uniquely smart, fully integrated treatment delivery, treatment planning and data management system. Hear from the Accuray team about this new, next-generation TomoTherapy platform, as well as how recent innovations to the CyberKnife platform reduce treatment time while providing leading-edge motion tracking and real-time beam adjustment.  Discover how Accuray systems can help clinicians deliver precise tumor treatments with confidence.

ASTRO Chairman of the Board David C. Beyer, MD, FASTRO, discusses the current trends in radiation oncology, key trends presented at this year's conference, and achieving value, and opportunities to improve value, in the treatment of prostate cancer.

Varian offered an overview of its new technology offerings at ASTRO 2015. These include advancements in analytics, treatment planning, adaptive therapy, clinical decision support and new tools for the integration of MRI and PET/CT into the treatment planning process. 

American Association of Physicists in Medicine (AAPM) President John Boone, Ph.D., discusses the impact of imaging in medical physics, as well as key topics addressed at this year’s meeting, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.

Suzanne Shankle, IBA product marketing specialist, explains how Dolphin helps provide better care and gives online control and confidence of treating patients safely.

AAPM President John E. Bayouth, Ph.D., discusses the impact of imaging in medical physics, as well as training that is available through AAPM, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.

Peter G. Maxim, Ph.D., assistant professor of radiation oncology at Stanford University, discusses stereotactic radiotherapy for renal sympathetic nerve ablation for the treatment of refractory hypertension, and some of the challenges involved, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.

AAPM President John Hazle, Ph.D., discusses trends in medical physics and major initiatives that the association is addressing in 2014 with Imaging Technology News Editorial Director Melinda Taschetta-Millane.

At ASTRO 2012, Ray Search Americas demonstrated the latest features for its radiation therapy treatment planning system.

Michael L. Steinberg, M.D., incoming president of the American Society for Radiation Oncology (ASTRO), presents highlights of the 2011 annual meeting, including an overview of educational programs and scientific sessions held during the event. Presentations included study findings regarding IMRT versus other forms of radiation therapy treatment for prostate cancer, as well as a study regarding hypofractionation of prostate cancer to decrease treatment time. Steinberg also describes some of ASTRO's other activities and gives his thoughts about challenges facing the membership during the coming year.

For more information: www.astro.org

IBA showcased its noninvasive radiation oncology treatment systems during the American Association of Physicists in Medicine (AAPM) 2011 annual meeting. This included its new Proteus One proton therapy system, advanced dose management and the addition of cone-beam computed tomography (CT) to help guide therapy.

For more information: www.IBA-protontherapy.com

IBA introduced its new Proteus One proton treatment system during ASTRO 2010. It is about one-third the size of current proton treatment systems, taking up about the same amount of space as two linac rooms side-by-side. The Proteus One is designed to offer more patient access to proton therapy by making the treatment system easier to install. It is also designed to be used as a single treatment room installation, rather than sharing a larger cyclotron and beam with several treatment rooms. For more information: www.iba-worldwide.com

American Association of Physicists in Medicine (AAPM) President Mike Herman, Ph.D., radiation oncology medical physicist, Mayo Clinic, explains the role of the society and its goal to improve patient care. Activities include sharing the latest scientific research, developing best practices, education, setting guidelines for certification and the roles of various staff under mediacl physicists, and how physicists can better serve their hospitals. The main focus in sessions at the AAPM annual meeting include patient safety concerning radiation dose and how to lower these doses in practice. Herman said AAPM is also calling for a national patient safety event recording process to make it easier to see where there are mistakes so they can be addressed. The society is also Herman said the process needs to be easy to access and use. He spoke to ITN at the some 2010, 52nd annual AAPM meeting 

Find more news and videos from AAPM meetings